目次

Table of Contents

Chapter 1. Research Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Segment Definitions
1.1.2. Product Type
1.1.3. Service Type
1.1.4. End-use
1.2. Regional Scope
1.3. Estimates And Forecast Timeline
1.4. Objectives
1.4.1. Objective-1
1.4.2. Objective-2
1.4.3. Objective-3
1.5. Research Methodology
1.6. Information Procurement
1.6.1. Purchased Database
1.6.2. GVR’s Internal Database
1.6.3. Secondary Sources
1.6.4. Primary Research
1.7. Information Or Data Analysis
1.7.1. Data Analysis Models
1.8. Market Formulation & Validation
1.9. Model Details
1.9.1. Commodity Flow Analysis
1.9.2. Parent Market Analysis
1.10. List Of Secondary Sources
1.11. List Of Abbreviations

Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights

Chapter 3. Topical Drugs CDMO Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. High demand for non-invasive treatment options to boost sales of topical drugs
3.2.1.2. Growing pipeline of topical drugs
3.2.1.3. Growing research and development investments
3.2.2. Market Restraint Analysis
3.2.2.1. Compliance with strict regulatory requirements
3.2.2.2. Limited efficacy in certain conditions limits adoption of topical products
3.3. Topical Drugs CDMO Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Supplier Power
3.3.1.2. Buyer Power
3.3.1.3. Substitution Threat
3.3.1.4. Threat Of New Entrant
3.3.1.5. Competitive Rivalry
3.3.2. PESTEL Analysis
3.3.3. COVID-19 Impact Analysis

Chapter 4. Topical Drugs CDMO Market: Product Type Estimates & Trend Analysis
4.1. Topical Drugs CDMO Market, By Product Type: Segment Dashboard
4.2. Topical Drugs CDMO Market, By Product Type: Movement Analysis
4.3. Topical Drugs CDMO Market Estimates & Forecasts, By Product Type, 2018 - 2030
4.3.1. Semi-solid Formulations
4.3.1.1. Semi-solid Formulations Topical Drugs CDMO Market, 2018 to 2030 (USD Million)
4.3.1.2. Creams
4.3.1.2.1. Creams Topical Drugs CDMO Market, 2018 to 2030 (USD Million)
4.3.1.3. Ointments
4.3.1.3.1. Ointments Topical Drugs CDMO Market, 2018 to 2030 (USD Million)
4.3.1.4. Gel
4.3.1.4.1. Gel Topical Drugs CDMO Market, 2018 to 2030 (USD Million)
4.3.1.5. Others
4.3.1.5.1. Others Topical Drugs CDMO Market, 2018 to 2030 (USD Million)
4.3.2. Liquid Formulations Drugs
4.3.2.1. Liquid Formulations Drugs Topical Drugs CDMO Market, 2018 to 2030 (USD Million)
4.3.3. Solid Formulations
4.3.3.1. Solid Formulations Topical Drugs CDMO Market, 2018 to 2030 (USD Million)
4.3.4. Transdermal Products
4.3.4.1. Transdermal Products Topical Drugs CDMO Market, 2018 to 2030 (USD Million)

Chapter 5. Topical Drugs CDMO Market: Service Type Estimates & Trend Analysis
5.1. Topical Drugs CDMO Market, By Service Type: Segment Dashboard
5.2. Topical Drugs CDMO Market, By Service Type: Movement Analysis
5.3. Topical Drugs CDMO Market Estimates & Forecasts, By Service Type, 2018 - 2030
5.3.1. Contract Development
5.3.1.1. Contract Development Topical Drugs CDMO Market, 2018 to 2030 (USD Million)
5.3.2. Contract Manufacturing
5.3.2.1. Contract Manufacturing Topical Drugs CDMO Market, 2018 to 2030 (USD Million)

Chapter 6. Topical Drugs CDMO Market: End-use Estimates & Trend Analysis
6.1. Topical Drugs CDMO Market, By End-use: Segment Dashboard
6.2. Topical Drugs CDMO Market, By End-use: Movement Analysis
6.3. Topical Drugs CDMO Market Estimates & Forecasts, By End-use, 2018 - 2030
6.3.1. Pharmaceutical Companies
6.3.1.1. Pharmaceutical Companies Topical Drugs CDMO Market 2018 to 2030 (USD Million)
6.3.2. Biopharmaceutical Companies
6.3.2.1. Biopharmaceutical Companies Topical Drugs CDMO Market 2018 to 2030 (USD Million)
6.3.3. Others
6.3.3.1. Others Topical Drugs CDMO Market 2018 to 2030 (USD Million)

Chapter 7. Topical Drugs CDMO Market: Regional Estimates & Trend Analysis
7.1. Regional Market Share Analysis, 2023 & 2030
7.2. Regional Market Dashboard
7.3. Global Regional Market Snapshot
7.4. North America
7.4.1. Market Estimates and Forecast, 2018 - 2030 (Revenue, USD Million)
7.4.2. U.S.
7.4.2.1. Key Country Dynamics
7.4.2.2. Competitive Scenario
7.4.2.3. Regulatory Framework
7.4.2.4. U.S. Market Estimates and Forecasts, 2018 - 2030
7.4.3. Canada
7.4.3.1. Key Country Dynamics
7.4.3.2. Competitive Scenario
7.4.3.3. Regulatory Framework
7.4.3.4. Canada Market Estimates and Forecasts, 2018 - 2030
7.5. Europe
7.5.1. UK
7.5.1.1. Key Country Dynamics
7.5.1.2. Competitive Scenario
7.5.1.3. Regulatory Framework
7.5.1.4. UK Market Estimates and Forecasts, 2018 - 2030
7.5.2. Germany
7.5.2.1. Key Country Dynamics
7.5.2.2. Competitive Scenario
7.5.2.3. Regulatory Framework
7.5.2.4. Germany Market Estimates and Forecasts, 2018 - 2030
7.5.3. France
7.5.3.1. Key Country Dynamics
7.5.3.2. Competitive Scenario
7.5.3.3. Regulatory Framework
7.5.3.4. France Market Estimates and Forecasts, 2018 - 2030
7.5.4. Italy
7.5.4.1. Key Country Dynamics
7.5.4.2. Competitive Scenario
7.5.4.3. Regulatory Framework
7.5.4.4. Italy Market Estimates and Forecasts, 2018 - 2030
7.5.5. Spain
7.5.5.1. Key Country Dynamics
7.5.5.2. Competitive Scenario
7.5.5.3. Regulatory Framework
7.5.5.4. Spain Market Estimates and Forecasts, 2018 - 2030
7.5.6. Denmark
7.5.6.1. Key Country Dynamics
7.5.6.2. Competitive Scenario
7.5.6.3. Regulatory Framework
7.5.6.4. Denmark Market Estimates and Forecasts, 2018 - 2030
7.5.7. Sweden
7.5.7.1. Key Country Dynamics
7.5.7.2. Competitive Scenario
7.5.7.3. Regulatory Framework
7.5.7.4. Sweden Market Estimates and Forecasts, 2018 - 2030
7.5.8. Norway
7.5.8.1. Key Country Dynamics
7.5.8.2. Competitive Scenario
7.5.8.3. Regulatory Framework
7.5.8.4. Norway Market Estimates and Forecasts, 2018 - 2030
7.6. Asia Pacific
7.6.1. Japan
7.6.1.1. Key Country Dynamics
7.6.1.2. Competitive Scenario
7.6.1.3. Regulatory Framework
7.6.1.4. Japan Market Estimates and Forecasts, 2018 - 2030
7.6.2. India
7.6.2.1. Key Country Dynamics
7.6.2.2. Competitive Scenario
7.6.2.3. Regulatory Framework
7.6.2.4. India Market Estimates and Forecasts, 2018 - 2030
7.6.3. China
7.6.3.1. Key Country Dynamics
7.6.3.2. Competitive Scenario
7.6.3.3. Regulatory Framework
7.6.3.4. China Market Estimates and Forecasts, 2018 - 2030
7.6.4. South Korea
7.6.4.1. Key Country Dynamics
7.6.4.2. Competitive Scenario
7.6.4.3. Regulatory Framework
7.6.4.4. South Korea Market Estimates and Forecasts, 2018 - 2030
7.6.5. Australia
7.6.5.1. Key Country Dynamics
7.6.5.2. Competitive Scenario
7.6.5.3. Regulatory Framework
7.6.5.4. Australia Market Estimates and Forecasts, 2018 - 2030
7.6.6. Thailand
7.6.6.1. Key Country Dynamics
7.6.6.2. Competitive Scenario
7.6.6.3. Regulatory Framework
7.6.6.4. Thailand Market Estimates and Forecasts, 2018 - 2030
7.7. Latin America
7.7.1. Brazil
7.7.1.1. Key Country Dynamics
7.7.1.2. Competitive Scenario
7.7.1.3. Regulatory Framework
7.7.1.4. Brazil Market Estimates and Forecasts, 2018 - 2030
7.7.2. Mexico
7.7.2.1. Key Country Dynamics
7.7.2.2. Competitive Scenario
7.7.2.3. Regulatory Framework
7.7.2.4. Mexico Market Estimates and Forecasts, 2018 - 2030
7.7.3. Argentina
7.7.3.1. Key Country Dynamics
7.7.3.2. Competitive Scenario
7.7.3.3. Regulatory Framework
7.7.3.4. Argentina Market Estimates and Forecasts, 2018 - 2030
7.8. MEA
7.8.1. South Africa
7.8.1.1. Key Country Dynamics
7.8.1.2. Competitive Scenario
7.8.1.3. Regulatory Framework
7.8.1.4. South Africa Market Estimates and Forecasts, 2018 - 2030
7.8.2. Saudi Arabia
7.8.2.1. Key Country Dynamics
7.8.2.2. Competitive Scenario
7.8.2.3. Regulatory Framework
7.8.2.4. Saudi Arabia Market Estimates and Forecasts, 2018 - 2030
7.8.3. UAE
7.8.3.1. Key Country Dynamics
7.8.3.2. Competitive Scenario
7.8.3.3. Regulatory Framework
7.8.3.4. UAE Market Estimates and Forecasts, 2018 - 2030
7.8.4. Kuwait
7.8.4.1. Key Country Dynamics
7.8.4.2. Competitive Scenario
7.8.4.3. Regulatory Framework
7.8.4.4. Kuwait Market Estimates and Forecasts, 2018 - 2030

Chapter 8. Competitive Landscape
8.1. Market Participant Categorization
8.1.1. Innovators
8.1.2. Market Leaders
8.1.3. Emerging Players
8.1.4. Company Market Share Analysis, 2023
8.2. Company Profiles
8.2.1. Lubrizol Life Science
8.2.1.1. Company Overview
8.2.1.2. Financial Performance
8.2.1.3. Service Benchmarking
8.2.1.4. Strategic Initiatives
8.2.2. Cambrex Corporation
8.2.2.1. Company Overview
8.2.2.2. Financial Performance
8.2.2.3. Service Benchmarking
8.2.2.4. Strategic Initiatives
8.2.3. Contract Pharmaceuticals Limited
8.2.3.1. Company Overview
8.2.3.2. Financial Performance
8.2.3.3. Service Benchmarking
8.2.3.4. Strategic Initiatives
8.2.4. Bora Pharmaceutical CDMO
8.2.4.1. Company Overview
8.2.4.2. Financial Performance
8.2.4.3. Service Benchmarking
8.2.4.4. Strategic Initiatives
8.2.5. Ascendia Pharmaceuticals
8.2.5.1. Company Overview
8.2.5.2. Financial Performance
8.2.5.3. Service Benchmarking
8.2.5.4. Strategic Initiatives
8.2.6. Pierre Fabre group
8.2.6.1. Company Overview
8.2.6.2. Financial Performance
8.2.6.3. Service Benchmarking
8.2.6.4. Strategic Initiatives
8.2.7. Piramal Pharma Solutions
8.2.7.1. Company Overview
8.2.7.2. Financial Performance
8.2.7.3. Service Benchmarking
8.2.7.4. Strategic Initiatives
8.2.8. DPT Laboratories, LTD
8.2.8.1. Company Overview
8.2.8.2. Financial Performance
8.2.8.3. Service Benchmarking
8.2.8.4. Strategic Initiatives
8.2.9. MedPharm Ltd
8.2.9.1. Company Overview
8.2.9.2. Financial Performance
8.2.9.3. Service Benchmarking
8.2.9.4. Strategic Initiatives
8.2.10. PCI Pharma Services
8.2.10.1. Company Overview
8.2.10.2. Financial Performance
8.2.10.3. Service Benchmarking
8.2.10.4. Strategic Initiatives

List of Tables
Table 1 List of secondary sources
Table 2 List of Abbreviations
Table 3 North America Topical Drugs CDMO market, by region, 2018 - 2030 (USD Million)
Table 4 North America Topical Drugs CDMO market, by Service Type, 2018 - 2030 (USD Million)
Table 5 North America Topical Drugs CDMO market, by Product Type, 2018 - 2030 (USD Million)
Table 6 North America Topical Drugs CDMO market, by Semi-solid Formulations, 2018 - 2030 (USD Million)
Table 7 North America Topical Drugs CDMO market, by End-use, 2018 - 2030 (USD Million)
Table 8 U.S. Topical Drugs CDMO market, by Service Type, 2018 - 2030 (USD Million)
Table 9 U.S. Topical Drugs CDMO market, by Product Type, 2018 - 2030 (USD Million)
Table 10 U.S. Topical Drugs CDMO market, by Semi-solid Formulations, 2018 - 2030 (USD Million)
Table 11 U.S. Topical Drugs CDMO market, by End-use, 2018 - 2030 (USD Million)
Table 12 Canada Topical Drugs CDMO market, by Service Type, 2018 - 2030 (USD Million)
Table 13 Canada Topical Drugs CDMO market, by Product Type, 2018 - 2030 (USD Million)
Table 14 Canada Topical Drugs CDMO market, by Semi-solid Formulations, 2018 - 2030 (USD Million)
Table 15 Canada Topical Drugs CDMO market, by End-use, 2018 - 2030 (USD Million)
Table 16 Europe Topical Drugs CDMO market, by region, 2018 - 2030 (USD Million)
Table 17 Europe Topical Drugs CDMO market, by Service Type, 2018 - 2030 (USD Million)
Table 18 Europe Topical Drugs CDMO market, by Product Type, 2018 - 2030 (USD Million)
Table 19 Europe Topical Drugs CDMO market, by Semi-solid Formulations, 2018 - 2030 (USD Million)
Table 20 Europe Topical Drugs CDMO market, by End-use, 2018 - 2030 (USD Million)
Table 21 UK Topical Drugs CDMO market, by Service Type, 2018 - 2030 (USD Million)
Table 22 UK Topical Drugs CDMO market, by Product Type, 2018 - 2030 (USD Million)
Table 23 UK Topical Drugs CDMO market, by Semi-solid Formulations, 2018 - 2030 (USD Million)
Table 24 UK Topical Drugs CDMO market, by End-use, 2018 - 2030 (USD Million)
Table 25 Germany Topical Drugs CDMO market, by Service Type, 2018 - 2030 (USD Million)
Table 26 Germany Topical Drugs CDMO market, by Product Type, 2018 - 2030 (USD Million)
Table 27 Germany Topical Drugs CDMO market, by Semi-solid Formulations, 2018 - 2030 (USD Million)
Table 28 Germany Topical Drugs CDMO market, by End-use, 2018 - 2030 (USD Million)
Table 29 France Topical Drugs CDMO market, by Service Type, 2018 - 2030 (USD Million)
Table 30 France Topical Drugs CDMO market, by Product Type, 2018 - 2030 (USD Million)
Table 31 France Topical Drugs CDMO market, by Semi-solid Formulations, 2018 - 2030 (USD Million)
Table 32 France Topical Drugs CDMO market, by End-use, 2018 - 2030 (USD Million)
Table 33 Italy Topical Drugs CDMO market, by Service Type, 2018 - 2030 (USD Million)
Table 34 Italy Topical Drugs CDMO market, by Product Type, 2018 - 2030 (USD Million)
Table 35 Italy Topical Drugs CDMO market, by Semi-solid Formulations, 2018 - 2030 (USD Million)
Table 36 Italy Topical Drugs CDMO market, by End-use, 2018 - 2030 (USD Million)
Table 37 Spain Topical Drugs CDMO market, by Service Type, 2018 - 2030 (USD Million)
Table 38 Spain Topical Drugs CDMO market, by Product Type, 2018 - 2030 (USD Million)
Table 39 Spain Topical Drugs CDMO market, by Semi-solid Formulations, 2018 - 2030 (USD Million)
Table 40 Spain Topical Drugs CDMO market, by End-use, 2018 - 2030 (USD Million)
Table 41 Denmark Topical Drugs CDMO market, by Service Type, 2018 - 2030 (USD Million)
Table 42 Denmark Topical Drugs CDMO market, by Product Type, 2018 - 2030 (USD Million)
Table 43 Denmark Topical Drugs CDMO market, by Semi-solid Formulations, 2018 - 2030 (USD Million)
Table 44 Denmark Topical Drugs CDMO market, by End-use, 2018 - 2030 (USD Million)
Table 45 Sweden Topical Drugs CDMO market, by Service Type, 2018 - 2030 (USD Million)
Table 46 Sweden Topical Drugs CDMO market, by Product Type, 2018 - 2030 (USD Million)
Table 47 Sweden Topical Drugs CDMO market, by Semi-solid Formulations, 2018 - 2030 (USD Million)
Table 48 Sweden Topical Drugs CDMO market, by End-use, 2018 - 2030 (USD Million)
Table 49 Norway Topical Drugs CDMO market, by Service Type, 2018 - 2030 (USD Million)
Table 50 Norway Topical Drugs CDMO market, by Product Type, 2018 - 2030 (USD Million)
Table 51 Norway Topical Drugs CDMO market, by Semi-solid Formulations, 2018 - 2030 (USD Million)
Table 52 Norway Topical Drugs CDMO market, by End-use, 2018 - 2030 (USD Million)
Table 53 Asia Pacific Topical Drugs CDMO market, by region, 2018 - 2030 (USD Million)
Table 54 Asia Pacific Topical Drugs CDMO market, by Service Type, 2018 - 2030 (USD Million)
Table 55 Asia Pacific Topical Drugs CDMO market, by Product Type, 2018 - 2030 (USD Million)
Table 56 Asia Pacific Topical Drugs CDMO market, by Semi-solid Formulations, 2018 - 2030 (USD Million)
Table 57 Asia Pacific Topical Drugs CDMO market, by End-use, 2018 - 2030 (USD Million)
Table 58 China Topical Drugs CDMO market, by Service Type, 2018 - 2030 (USD Million)
Table 59 China Topical Drugs CDMO market, by Product Type, 2018 - 2030 (USD Million)
Table 60 China Topical Drugs CDMO market, by Semi-solid Formulations, 2018 - 2030 (USD Million)
Table 61 China Topical Drugs CDMO market, by End-use, 2018 - 2030 (USD Million)
Table 62 Japan Topical Drugs CDMO market, by Service Type, 2018 - 2030 (USD Million)
Table 63 Japan Topical Drugs CDMO market, by Product Type, 2018 - 2030 (USD Million)
Table 64 Japan Topical Drugs CDMO market, by Semi-solid Formulations, 2018 - 2030 (USD Million)
Table 65 Japan Topical Drugs CDMO market, by End-use, 2018 - 2030 (USD Million)
Table 66 India Topical Drugs CDMO market, by Service Type, 2018 - 2030 (USD Million)
Table 67 India Topical Drugs CDMO market, by Product Type, 2018 - 2030 (USD Million)
Table 68 India Topical Drugs CDMO market, by Semi-solid Formulations, 2018 - 2030 (USD Million)
Table 69 India Topical Drugs CDMO market, by End-use, 2018 - 2030 (USD Million)
Table 70 Australia Topical Drugs CDMO market, by Service Type, 2018 - 2030 (USD Million)
Table 71 Australia Topical Drugs CDMO market, by Product Type, 2018 - 2030 (USD Million)
Table 72 Australia Topical Drugs CDMO market, by Semi-solid Formulations, 2018 - 2030 (USD Million)
Table 73 Australia Topical Drugs CDMO market, by End-use, 2018 - 2030 (USD Million)
Table 74 South Korea Topical Drugs CDMO market, by Service Type, 2018 - 2030 (USD Million)
Table 75 South Korea Topical Drugs CDMO market, by Product Type, 2018 - 2030 (USD Million)
Table 76 South Korea Topical Drugs CDMO market, by Semi-solid Formulations, 2018 - 2030 (USD Million)
Table 77 South Korea Topical Drugs CDMO market, by End-use, 2018 - 2030 (USD Million)
Table 78 Thailand Topical Drugs CDMO market, by Service Type, 2018 - 2030 (USD Million)
Table 79 Thailand Topical Drugs CDMO market, by Product Type, 2018 - 2030 (USD Million)
Table 80 Thailand Topical Drugs CDMO market, by Semi-solid Formulations, 2018 - 2030 (USD Million)
Table 81 Thailand Topical Drugs CDMO market, by End-use, 2018 - 2030 (USD Million)
Table 82 Latin America Topical Drugs CDMO market, by region, 2018 - 2030 (USD Million)
Table 83 Latin America Topical Drugs CDMO market, by Service Type, 2018 - 2030 (USD Million)
Table 84 Latin America Topical Drugs CDMO market, by Product Type, 2018 - 2030 (USD Million)
Table 85 Latin America Topical Drugs CDMO market, by Semi-solid Formulations, 2018 - 2030 (USD Million)
Table 86 Latin America Topical Drugs CDMO market, by End-use, 2018 - 2030 (USD Million)
Table 87 Brazil Topical Drugs CDMO market, by Service Type, 2018 - 2030 (USD Million)
Table 88 Brazil Topical Drugs CDMO market, by Product Type, 2018 - 2030 (USD Million)
Table 89 Brazil Topical Drugs CDMO market, by Semi-solid Formulations, 2018 - 2030 (USD Million)
Table 90 Brazil Topical Drugs CDMO market, by End-use, 2018 - 2030 (USD Million)
Table 91 Mexico Topical Drugs CDMO market, by Service Type, 2018 - 2030 (USD Million)
Table 92 Mexico Topical Drugs CDMO market, by Product Type, 2018 - 2030 (USD Million)
Table 93 Mexico Topical Drugs CDMO market, by Semi-solid Formulations, 2018 - 2030 (USD Million)
Table 94 Mexico Topical Drugs CDMO market, by End-use, 2018 - 2030 (USD Million)
Table 95 Argentina Topical Drugs CDMO market, by Service Type, 2018 - 2030 (USD Million)
Table 96 Argentina Topical Drugs CDMO market, by Product Type, 2018 - 2030 (USD Million)
Table 97 Argentina Topical Drugs CDMO market, by Semi-solid Formulations, 2018 - 2030 (USD Million)
Table 98 Argentina Topical Drugs CDMO market, by End-use, 2018 - 2030 (USD Million)
Table 99 Middle East and Africa Topical Drugs CDMO market, by region, 2018 - 2030 (USD Million)
Table 100 Middle East and Africa Topical Drugs CDMO market, by Service Type, 2018 - 2030 (USD Million)
Table 101 Middle East and Africa Topical Drugs CDMO market, by Product Type, 2018 - 2030 (USD Million)
Table 102 Middle East & Africa Topical Drugs CDMO market, by Semi-solid Formulations, 2018 - 2030 (USD Million)
Table 103 Middle East and Africa Topical Drugs CDMO market, by End-use, 2018 - 2030 (USD Million)
Table 104 South Africa Topical Drugs CDMO market, by Service Type, 2018 - 2030 (USD Million)
Table 105 South Africa Topical Drugs CDMO market, by Product Type, 2018 - 2030 (USD Million)
Table 106 South Africa Topical Drugs CDMO market, by Semi-solid Formulations, 2018 - 2030 (USD Million)
Table 107 South Africa Topical Drugs CDMO market, by End-use, 2018 - 2030 (USD Million)
Table 108 Saudi Arabia Topical Drugs CDMO market, by Service Type, 2018 - 2030 (USD Million)
Table 109 Saudi Arabia Topical Drugs CDMO market, by Product Type, 2018 - 2030 (USD Million)
Table 110 Saudi Arabia Topical Drugs CDMO market, by Semi-solid Formulations, 2018 - 2030 (USD Million)
Table 111 Saudi Arabia Topical Drugs CDMO market, by End-use, 2018 - 2030 (USD Million)
Table 112 UAE Topical Drugs CDMO market, by Service Type, 2018 - 2030 (USD Million)
Table 113 UAE Topical Drugs CDMO market, by Product Type, 2018 - 2030 (USD Million)
Table 114 UAE Topical Drugs CDMO market, by Semi-solid Formulations, 2018 - 2030 (USD Million)
Table 115 UAE Topical Drugs CDMO market, by End-use, 2018 - 2030 (USD Million)
Table 116 Kuwait Topical Drugs CDMO market, by Service Type, 2018 - 2030 (USD Million)
Table 117 Kuwait Topical Drugs CDMO market, by Product Type, 2018 - 2030 (USD Million)
Table 118 Kuwait Topical Drugs CDMO market, by Semi-solid Formulations, 2018 - 2030 (USD Million)
Table 119 Kuwait Topical Drugs CDMO market, by End-use, 2018 - 2030 (USD Million)

List of Figures
Fig. 1 Market research process
Fig. 2 Information procurement
Fig. 3 Market research approaches
Fig. 4 QFD modeling for market share assessment
Fig. 5 Market formulation & validation
Fig. 6 Commodity flow analysis
Fig. 7 Primary research pattern
Fig. 8 Primary interviews in North America
Fig. 9 Primary interviews in Europe
Fig. 10 Primary interviews in the Asia Pacific
Fig. 11 Primary interviews in Latin America
Fig. 12 Primary interviews in MEA
Fig. 13 Market Snapshot
Fig. 14 Segment Snapshot
Fig. 15 Segment Snapshot
Fig. 16 Competitive Landscape Snapshot
Fig. 17 Topical Drugs CDMO market segmentation
Fig. 18 Parent market outlook (2023)
Fig. 19 Related/ancillary market outlook (2023)
Fig. 20 Market driver relevance analysis (Current & future impact)
Fig. 21 Market restraint relevance analysis (Current & future impact)
Fig. 22 Porter’s five forces analysis
Fig. 23 SWOT analysis, by a factor (political & legal, economic and technological)
Fig. 24 Topical Drugs CDMO Market Product Type outlook: Segment dashboard
Fig. 25 Topical Drugs CDMO: Product Type movement analysis
Fig. 26 Semi-solid Formulations market, 2018 - 2030 (USD Million)
Fig. 27 Creams market, 2018 - 2030 (USD Million)
Fig. 28 Ointments market, 2018 - 2030 (USD Million)
Fig. 29 Gel market, 2018 - 2030 (USD Million)
Fig. 30 Others market, 2018 - 2030 (USD Million)
Fig. 31 Liquid Formulations Drugs market, 2018 - 2030 (USD Million)
Fig. 32 Solid Formulations market, 2018 - 2030 (USD Million)
Fig. 33 Transdermal Products market, 2018 - 2030 (USD Million)
Fig. 34 Topical Drugs CDMO Market Service Type outlook: Segment dashboard
Fig. 35 Topical Drugs CDMO: Service Type type movement analysis
Fig. 36 Contract Development market, 2018 - 2030 (USD Million)
Fig. 37 Contract Manufacturing market, 2018 - 2030 (USD Million)
Fig. 38 Topical Drugs CDMO market End-use outlook: Segment dashboard
Fig. 39 Topical Drugs CDMO market: End-use movement analysis
Fig. 40 Pharmaceutical Companies market, 2018 - 2030 (USD Million)
Fig. 41 Biopharmaceutical Companies market, 2018 - 2030 (USD Million)
Fig. 42 Others market, 2018 - 2030 (USD Million)
Fig. 43 Regional marketplace: Segment dashboard
Fig. 44 Regional outlook, 2023 & 2030
Fig. 45 North America market, 2018 - 2030 (USD Million)
Fig. 46 U.S. market, 2018 - 2030 (USD Million)
Fig. 47 Canada market, 2018 - 2030 (USD Million)
Fig. 48 Europe market, 2018 - 2030 (USD Million)
Fig. 49 Germany market, 2018 - 2030 (USD Million)
Fig. 50 UK market, 2018 - 2030 (USD Million)
Fig. 51 France market, 2018 - 2030 (USD Million)
Fig. 52 Italy market, 2018 - 2030 (USD Million)
Fig. 53 Spain market, 2018 - 2030 (USD Million)
Fig. 54 Denmark market, 2018 - 2030(USD Million)
Fig. 55 Sweden market, 2018 - 2030 (USD Million)
Fig. 56 Norway market, 2018 - 2030 (USD Million)
Fig. 57 Asia Pacific market, 2018 - 2030 (USD Million)
Fig. 58 China market, 2018 - 2030 (USD Million)
Fig. 59 Japan market, 2018 - 2030 (USD Million)
Fig. 60 India market, 2018 - 2030 (USD Million)
Fig. 61 Australia market, 2018 - 2030 (USD Million)
Fig. 62 South Korea market, 2018 - 2030 (USD Million)
Fig. 63 Thailand market, 2018 - 2030 (USD Million)
Fig. 64 Latin America market, 2018 - 2030 (USD Million)
Fig. 65 Brazil market, 2018 - 2030 (USD Million)
Fig. 66 Mexico market, 2018 - 2030 (USD Million)
Fig. 67 Argentina market, 2018 - 2030 (USD Million)
Fig. 68 Middle East & Africa market, 2018 - 2030 (USD Million)
Fig. 69 South Africa market, 2018 - 2030 (USD Million)
Fig. 70 Saudi Arabia market, 2018 - 2030 (USD Million)
Fig. 71 UAE market, 2018 - 2030 (USD Million)
Fig. 72 Kuwait market, 2018 - 2030 (USD Million)